CEACAM5 and cancer: Serum miRNAs, including miR-126-3p, miR-182-5p, miR-183-5p, and miR-210-3p, were also detected to contain primary diagnosis compared for NSCLC, displaying the same sensibility and quality as usual malignant tumor biomarker carcinoembryonic antigen (CEA).